BRIEF-Cesca Therapeutics Q2 revenue rose 22 percent to $4.0 mln
Feb 13 Cesca Therapeutics Inc
* Cesca therapeutics reports second quarter fiscal 2017 financial results and provides business update
* Q2 revenue rose 22 percent to $4.0 million
* Says net loss was $3.4 million for three months ended december 31, 2016 Source text for Eikon: Further company coverage: